SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 32.31+1.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William L. Molair II who wrote (7874)11/29/1998 8:38:00 PM
From: Robert K.  Read Replies (1) of 17367
 
Willaim, I will attempt a answer. If dsmb meningo causes a halt of some sort, you should get info fairly quickly. If Dsmb meningo says
lets review the trial en toto, then its 90 some days past then till we find out which puts us in march-april. Now mind you we have dsmb
pneumonia/ards in feb-march timeframe. And we also have liver results prending. And we also have hu1124 (another c3 type drug)
pending about january. And we also have another indication pending.
Plus God knows what else. So you all can look to meningo, but we might see action elsewhere before then. Hope that helps :-)
All disclaimers on everything. Consider nothing as fact. :-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext